— Know what they know.
Not Investment Advice

LCI NYSE

Lannett Company, Inc.
1W: +47.4% 1M: -79.3% 3M: -98.7% 1Y: -99.6% 3Y: -100.0% 5Y: -100.0%
$0.69
Last traded 2023-05-23 — delisted
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · $7.4M mcap · 8M float · 2.48% daily turnover

📊 Key Metrics

TTM
$311M
Revenue
-16.6% YoY
$-259M
Net Income
+18.1% YoY
$-65M
Free Cash Flow
-353.5% YoY
18.8%
Gross Margin
-15.4%
Op. Margin
-126.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE90.7%
ROA-57.1%
ROIC-24.7%

Valuation

P/E-0.0
P/B-0.0
EV/EBITDA-5.4

Leverage

Debt/Equity-1.55
Current Ratio0.36
Interest Cov.-3.1x

Quality Scores

Piotroski F3/9
Altman Z-5.79
Beneish M-5.97

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms